Book an Appointment
Mr Parijat Bhattacharjee, Private Consultant Gynaecologist, Harrow, Brentford, Northwood, London, UK / Media / Videos » Menopause & Dementia

Menopause & Dementia

Menopause & Dementia
Posted on: 03-Jul-2026

This video, titled "Menopause & Dementia" by Gynae Consultant, reviews a December 2019 article published in the British Menopause Society journal, Post Reproductive Health, by Hornberger and his team from Norwich. The video explores the biological connection between estrogen loss and cognitive decline, alongside the medical controversy surrounding Hormone Replacement Therapy (HRT).

Prevalence and Timeline of Dementia

  • The Global Picture: According to a 2015 World Health Organization report, 47.5 million people worldwide live with dementia, with 7.7 million new cases added annually. While advanced age is the primary risk factor, lifestyle, genetics, and medication choices also contribute.
  • Early Changes: Although symptoms typically manifest in a person's 70s or 80s, the underlying pathophysiology in the brain begins nearly 20 years earlier.
  • Gender Differences: Women experience a higher rate of dementia immediately following menopause compared to men of the same age, though this disparity levels out by age 70.

The Link Between Estrogen and "Brain Fog"

During perimenopause and early post-menopause, women frequently experience "brain fog," characterized by forgetfulness, difficulty focusing, and memory lapses. A nationwide study of over 16,000 women showed that 31% of perimenopausal women and 41% of early postmenopausal women cited forgetfulness as a major symptom.

This symptom corresponds directly with how estrogen supports the brain:

  • Glucose Metabolism: Estrogen regulates glucose metabolism in the brain, which fuels cognitive function.
  • Neurotransmitters: Estrogen helps metabolize acetylcholine, a vital neurotransmitter responsible for attention and memory.
  • Brain Health: Estrogen plays a critical role in neurogenesis (the creation of new neurons) and maintaining brain homeostasis.

The Role of HRT: The "Critical Window Hypothesis"

The impact of HRT on dementia is a debated topic because historical population-based trials rarely looked at cognitive function as a primary outcome. However, a meta-analysis of over 50,000 women supports the Critical Window Hypothesis:

  • Beneficial Timing: If HRT is started early during perimenopause or early post-menopause (specifically in women under 60 years of age), it appears to have a protective, beneficial effect on memory and overall cognition.
  • Harmful Timing: If HRT is initiated late (after 65 years of age), it can have a negative, deleterious effect, potentially accelerating cognitive decline and increasing dementia risks.

Mechanisms in Alzheimer's Disease and Genetics

Alzheimer's disease is the most common form of dementia, accounting for two-thirds of all cases. It involves the neurotoxic accumulation of insoluble proteins: beta-amyloid plaques (scattered across the brain) and neurofibrillary tau tangles (which begin in the hippocampus and medial temporal lobe before spreading).

  • Animal Data: Lab studies on rats without ovaries show that estrogen replacement increases dendritic synapses in the hippocampus and may actively prevent the accumulation of beta-amyloid plaques.
  • The Genetic Factor: The Apolipoprotein E4 (APOE4) gene significantly drives Alzheimer's risk. Individuals carrying two copies of this allele (homozygous) face a 12-fold increased risk of developing the disease, while those with one copy (heterozygous) face a 4-fold increase. Because estrogen interacts directly with the physiological pathways of this gene, timely hormone management remains highly relevant.

The video concludes by echoing the authors' call for more dedicated, high-quality clinical studies to firmly define these neuroprotective boundaries.